Welchol colesevelam regulatory update

FDA approved an sNDA from Daiichi for Welchol colesevelam as an adjunct to diet and exercise to reduce elevated low-density lipoprotein cholesterol (LDL-C) in boys and postmenarchal girls ages 10-17 w...